Only half of US adults say they would receive a coronavirus disease 2019 (COVID-19) vaccine should it become available; diagnoses of colorectal cancer fell during March and April; slow uptake led to delays in a child hunger prevention program.
A new Associated Press—NORC Center for Public Affairs Research poll found roughly half of American adults (49%) would get a coronavirus disease 2019 (COVID-19) vaccine if scientists working to produce one succeed. The poll found that 1 in 5 of those surveyed would refuse the vaccine while 31% were not sure if they would get vaccinated. Of those who say they will not receive the vaccine, 70% cite safety as their top concern. For those who would receive a vaccine, top motivators include protecting themselves, their family, and the community they live in.
New diagnoses of colorectal cancer fell by more than 32% in March and April in the United States, due to postponed screenings and appointments, Reuters reports. Colorectal cancer is the second leading cause of cancer deaths in the United States. The number of performed colonoscopies and biopsies fell by around 90% between mid-March and mid-April compared with the same period in 2019, according to research from Komodo Health. In addition, colorectal cancer surgeries fell by 53%. Screenings are vital to catching the disease early on, as the 5-year survival rate is near 90%.
Pandemic-EBT, a hunger prevention program instituted in response to the COVID-19 pandemic, has only benefitted 15% of eligible children since the program’s inception in March, The New York Times reports. Originally intended to aid 30 million children across the country, Pandemic-EBT was created to compensate children for free meals they would usually receive in school via electronic vouchers that can be used in grocery stores. However, only 12 states have started sending the benefits to parents of eligible children while 16 states lack federal approval to begin distributing payments.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More